APA (7th ed.) Citation

Y, M., T, K., R, S., R, O., T, I., Y, M., . . . PM, R. (2018). Glycosylation engineering of therapeutic IgG antibodies: Challenges for the safety, functionality and efficacy. Protein & cell, 9(1), 47. https://doi.org/10.1007/s13238-017-0433-3

Chicago Style (17th ed.) Citation

Y, Mimura, et al. "Glycosylation Engineering of Therapeutic IgG Antibodies: Challenges for the Safety, Functionality and Efficacy." Protein & Cell 9, no. 1 (2018): 47. https://doi.org/10.1007/s13238-017-0433-3.

MLA (9th ed.) Citation

Y, Mimura, et al. "Glycosylation Engineering of Therapeutic IgG Antibodies: Challenges for the Safety, Functionality and Efficacy." Protein & Cell, vol. 9, no. 1, 2018, p. 47, https://doi.org/10.1007/s13238-017-0433-3.